Patrice Francois
University of Münster
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Patrice Francois.
Journal of Biological Chemistry | 1999
Elaine F. Corbett; Kim Oikawa; Patrice Francois; Daniel C. Tessier; Cyril M. Kay; John J. M. Bergeron; David Y. Thomas; Karl-Heinz Krause; Marek Michalak
Casade Blue (CB), a fluorescent dye, was used to investigate the dynamics of interactions between endoplasmic reticulum (ER) lumenal chaperones including calreticulin, protein disulfide isomerase (PDI), and ERp57. PDI and ERp57 were labeled with CB, and subsequently, we show that the fluorescence intensity of the CB-conjugated proteins changes upon exposure to microenvironments of a different polarity. CD analysis of the purified proteins revealed that changes in the fluorescence intensity of CB-ERp57 and CB-PDI correspond to conformational changes in the proteins. Using this technique we demonstrate that PDI interacts with calreticulin at low Ca2+ concentration (below 100 μm), whereas the protein complex dissociates at >400 μmCa2+. These are the Ca2+ concentrations reminiscent of Ca2+ levels found in empty or full ER Ca2+ stores. The N-domain of calreticulin interacts with PDI, but Ca2+ binding to the C-domain of the protein is responsible for Ca2+ sensitivity of the interaction. ERp57 also interacts with calreticulin through the N-domain of the protein. Initial interaction between these proteins is Ca2+-independent, but it is modulated by Ca2+binding to the C-domain of calreticulin. We conclude that changes in ER lumenal Ca2+ concentration may be responsible for the regulation of protein-protein interactions. Calreticulin may play a role of Ca2+ “sensor” for ER chaperones via regulation of Ca2+-dependent formation and maintenance of structural and functional complexes between different proteins involved in a variety of steps during protein synthesis, folding, and post-translational modification.
Journal of Biological Chemistry | 2004
Carmelo Bisognano; William L. Kelley; Tristan Estoppey; Patrice Francois; Jacques Schrenzel; Dongmei Li; Daniel Pablo Lew; David C. Hooper; Ambrose L. Cheung; Pierre Vaudaux
Subinhibitory concentrations of ciprofloxacin (CPX) raise the fibronectin-mediated attachment of fluoroquinolone-resistant Staphylococcus aureus by selectively inducing fnbB coding for one of two fibronectin-binding proteins: FnBPB. To identify candidate regulatory pathway(s) linking drug exposure to up-regulation of fnbB, we disrupted the global response regulators agr, sarA, and recA in the highly quinolone-resistant strain RA1. Whereas agr and sarA mutants of RA1 exposed to CPX still displayed increased adhesion to fibronectin, the CPX-triggered response was abolished in the uvs-568 recA mutant, but was restored following complementation with wild type recA. Steady-state levels of recA and fnbB, but not fnbA, mRNA were co-coordinately increased >3-fold in CPX-exposed strain RA1. Electrophoretic mobility shift assays revealed specific binding of purified S. aureus SOS-repressor LexA to recA and fnbB, but not to fnbA or rpoB promoters. DNase I footprint analysis showed LexA binding overlapping the core promoter elements in fnbB. We conclude that activation of recA and derepression of lexA-regulated genes by CPX may represent a response to drug-induced damage that results in a novel induction of a virulence factor leading to increased bacterial tissue adherence.
Journal of Biological Chemistry | 1999
Patrice Francois; Klaus T. Preissner; Rosaria P. Haugland; P. Vaudaux; Daniel Pablo Lew; Karl-Heinz Krause
Vitronectin (VN) is a high affinity heparin-binding protein. The physiological role of this binding has hitherto received little attention, and its molecular determinants are subject to controversy. In this study, we characterized vitronectin interaction with heparin, heparin analogues, bacterial extracts, and cell surface glycosaminoglycans. As assessed by (i) fluorescence assays, (ii) precipitation with heparin-Sepharose beads, or (iii) Western blotting with antibodies against VN347–361(the heparin-binding site), we demonstrate an exposure of the VN heparin-binding site in multimeric but not monomeric vitronectin. Through its heparin-binding site, vitronectin also bound other glycosaminoglycans and Staphylococcus aureus extracts. The kinetics of heparin binding to vitronectin were complex. After a fast association phase (τ = 0.3 s), a slow conversion of an unstable to a stable heparin-vitronectin complex (τ = 180 s) occurred. Heparin binding kinetics and transition to a stable complex were mimicked by VN347–361, demonstrating that this area is the fully functional heparin-binding site of vitronectin. Multimeric vitronectin bound to endothelial cells. This binding was blocked by soluble heparin and was not observed when endothelial cells were pretreated with glycosaminoglycan-removing enzymes. Glycosaminoglycan-dependent interaction of endothelial cells with multimeric vitronectin might be a relevant mechanism for removal of multimeric vitronectin from plasma. Conversion of an unstable to a stable glycosaminoglycan-vitronectin complex is likely to be relevant for association with endothelial cells under flow conditions.
Archive | 2013
Patrice Francois; Jacques Schrenzel
Staphylococcus aureus is a major pathogen responsible for both nosocomial and community-acquired infections. While the first S. aureus isolates displaying resistance to methicillin (MRSA) were reported in the early 1960s [1], endemic strains of MRSA carrying multiple resistance determinants have become a worldwide nosocomial problem only in the early 1980s [2]. The presence of MRSA in an institution is paralleled by an increased rate of bacteremia, or other severe MRSA infections [3]. MRSA-related bacteremia carries a threefold attributable cost and a threefold excess length of hospital stay when compared with methicillin-susceptible S. aureus (MSSA) bacteremia [4].
Archive | 2000
Pierre Vaudaux; Patrice Francois; Daniel Pablo Lew; Francis Waldvogel
Archive | 2003
Jacques Schrenzel; Patrice Francois; Yvan Charbonnier; Jean Jacquet; Dominic Utinger; Gerhard M. Kresbach; Andreas P. Abel; Markus Ehrat
Archive | 2003
Jacques Schrenzel; Patrice Francois; Yvan Charbonnier; Jean Jacquet; Utinger Dominic; Gerhard M. Kresbach; Andreas P. Abel; Markus Ehrat
Detection of Highly Dangerous Pathogens: Microarray Methods for BSL 3 and BSL 4 Agents | 2009
Jacques Schrenzel; Tanja Kostić; Levente Bodrossy; Patrice Francois
Archive | 2012
Cindy Lamamy; Aline Berthelot; Xavier Bertrand; Anne-Sophie Valentin; Sophie Thiais; Virginie Morange; Nicole Girard; Pierre-Yves Donnio; Jacques Schrenzel; Patrice Francois; Nathalie van der Mee-Marquet
Archive | 2011
Amar Rida; Nicolas Mermod; Patrice Francois; Vladimir Lazarevic; Jacques Schrenzel